Interleukin-10 (IL-10) is a multifunctional cytokine with diverse effects in most hematopoietic cell types. 1 The principal role of IL-10 appears to be to limit and ultimately terminate inflammatory responses, consistent with the development of chronic inflammatory bowel disease in the IL-10 knockout mice. 2 In contrast to other cytokines, IL-10 gene has homologs in several virus genomes, evidencing its crucial regulatory activity in immune and inflammatory responses. 3, 4 There have been apparent discrepancies between the effect of IL-10 on a number of animal models of spontaneous autoimmune diabetes. However, it seems that pathogenesis has finally been correlated with autoreactive T-helper production of the type 1 cytokine interferon-gamma, while protection from disease was associated with type 2 cytokines such as interleukin-4 and IL-10. [5] [6] [7] Supporting this imbalance between Th1 and Th2 responses as a causative agent of the proinflammatory activity that leads to type 1 diabetes (T1D) is the suppression of autoimmune diabetes by viral IL-10 gene transfer in NOD mice. 8, 9 Autoimmune diabetes (T1D; 0.4% prevalence) in humans may as well be caused by disregulation of the immune system leading to hyporesponsiveness of regulatory Th2 cells and activation of effector Th1 cells.
There is evidence of a decreased function of Th2 cells and therefore diminished production of IL-10, rather than overactivation of Th1 subset in the peripheral blood of prediabetic subjects. 10 It has been reported that the production of Th2 type cytokines differed between twins discordant for T1D, showing an association between their secretion patterns and disease risk.
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The IL-10 gene, located on the long arm of human chromosome 1, presents two CA-repeat microsatellites in the 5 0 -flanking region: IL-10R and IL-10G, at À4 and À1.1 kb, respectively. [12] [13] [14] In addition, three single nucleotide polymorphisms (SNPs) in its promoter at positions À1082 (G/A), À819 (C/T) and À592 (C/A) have been identified. These polymorphisms might configure several different haplotypes, but only three, ATA, ACC and GCC, have been described in Caucasian populations. The IL-10 mRNA synthesis rate and ultimately the cytokine production depend on the final configuration of the gene. 15, 16 Functional studies on IL-10 polymorphisms have been inconclusive, presumably due to differences in experimental conditions (LPS in whole blood vs ConA in T cells), with both À1082A 17 and IL-10R*3 16 reported to be associated with lower production, and allele IL-10G*14 as a high producer. As -1082G and IL-10R3 alleles are in linkage disequilibrium in our 18 and other populations, the results are difficult to reconcile. Moreover, additional SNPs in the distal IL-10 promoter (À2763, À2849 and À3575) have been described to affect IL-10 production, although the extended haplotypes formed with the proximal promoter positions do not fully explain the association with this cytokine levels. 19 This work showed the physical linkage of the distal promoter haplotype contributing to high IL-10 production with all three proximal haplotypes present in Caucasians, and the linkage of the third proximal haplotype with both high and mainly low production distal haplotypes.
We aimed to describe for the first time in a Caucasian population the association of these two microsatellites and three proximal promoter IL-10 genetic polymorphisms to autoimmune diabetes. Genetic association between IL-10 promoter polymorphisms and T1D either age at onset 20 or clinical heterogeneity 21 in the Japanese population has been previously reported.
Th1 responses are claimed to be harmful in several organ-specific autoimmune diseases. We attempt to study the role of IL-10 gene polymorphisms as risk modifiers for T1D. Our group has already published family and case-control studies on the association of these IL-10 polymorphisms with other Th1 autoimmune diseases in the Spanish population. In multiple sclerosis (MS) and rheumatoid arthritis (RA), a significant association was found with the IL-10G*12 allele, but not with the promoter SNPs or the other microsatellite, IL-10R. In both diseases, this IL-10G*12 allele was not only significantly increased when cases and ethnically matched controls were compared but it was also more often transmitted than not transmitted to patients from heterozygous parents. 18, 22 We postulate the contribution of IL-10 in the regulation and control of inflammation in T1D, and we aimed at testing its role in a case-control study. In all, 294 Caucasian T1D patients (146 men and 148 women) and 574 healthy unrelated controls from the same Madrid area were consecutively recruited after informed consent was obtained from the participating subjects or their parents. The age at onset for the T1D patients range from 1 to 55 years old (median onset: 18 years old). The diagnosis was based on patients' clinical features and laboratory data according to the criteria of the American Diabetes Association (ADA). All subjects were insulin-dependent at the time of the study. The control subjects were ethnically matched blood donors.
The distribution of alleles for both the proximal promoter SNPs and the two microsatellites studied in the control group was similar to that already described in other Caucasian populations. The alleles found at a higher frequency were IL-10R*2 and IL-10G*9 and IL-10G*13, while IL-10R*1 and IL-10G*1-G*6 were extremely rare. The carrier rate of the IL-10G*12 allele, that is the number of individuals presenting this specific allele, was compared between T1D patients and healthy controls ( Table 1) . We found an OR41, which might indicate a trend similar to the association already seen for MS and RA, and as our a priori hypothesis could save the need for Bonferroni's correction. DR3 and DR4 being the highest risk HLA determinants, we performed an association study of IL-10G*12 with HLA status. No differences were observed when IL-10G*12 was tested either in the DR3 positive vs negative or DR4 positive vs negative groups (data not shown). When the other IL-10R microsatellite was studied, the most frequent allele found was IL-10R*2, in keeping with previous reports. No statistically significant association with this marker was detected.
Neither one of the three proximal promoter SNPs nor any of the three proximal promoter haplotypes already described in Caucasoid populations was found to be associated with T1D (Table 2) . Their haplotypic distribution among patients and controls was equivalent and consequently these SNPs do not affect T1D susceptibility per se. The proximal promoter haplotypes ATA and ACC are associated with high levels of the cytokine, while the GCC haplotype is mainly associated with lower IL-10 production. 19 However, the association between the distal haplotypes and IL-10 production is not absolute and additional factors must underlie the tight genetic control of these cytokine production levels. 23 Genetic susceptibility to T1D is multifactorial, the HLA region contribution being the strongest. Genome-wide scans have demonstrated that T1D is a polygenetic trait, but HLA has been the only one consistently reproduced in all of them, probably due to the minor effects of other loci. Case-control studies of a candidate genetic region are an alternative more sensitive approach to discover susceptibility loci of a lesser risk impact. It seemed reasonable to expect an influence of IL-10 in the Th1/Th2 status of the immune response in T1D. A modest trend of association exists in our population with the IL-10G*12 allele. This is the first association report on T1D susceptibility and IL-10 polymorphisms in Caucasians, and is in agreement with previous results obtained by our group in multiple sclerosis and rheumatoid arthritis. In the three autoimmune diseases studied, the IL-10G*12 appear in a total of 150 out of the 886 patients vs 63 of the 574 matched controls, which renders a significant difference P ¼ 0.002, OR ¼ 1.64. This relative risk reflects the prevailing situation in most autoimmune diseases: susceptibility is only modestly associated with any specific non-MHC locus, despite the potent role for IL-10 association with T1D E Urcelay et al genetic predisposition due to the combined impact of multiple contributing susceptibility genes. This analysis not only showed that the presence of the associated IL-10G*12 marker may be considered at best as a minor risk factor for T1D but suggests a possible shared genetic basis among diverse autoimmune diseases. These results support the hypothesis that a common set of susceptibility genes may control human immune diseases with very different clinical presentations. [24] [25] [26] These autoimmune genes operative in different diseases probably regulate the severity, age at onset and prognosis in a particular patient. A better understanding of the epistatic effects of the genes involved in multifactorial diseases will lead to common early diagnostic criteria and therapeutic strategies. IL-10 promoter polymorphisms were studied by allele-specific PCR with oligonucleotides labeled with distinct fluorochromes essentially as described. 18, 27 In short, a combined amplification of the IL-10G microsatellite and the promoter SNPs was performed, and therefore amplification only proceeds when the markers are located in cis. This typing method allowed constructing haplotypes directly. a The third position has been determined for 333 out of the 520 controls and no single exception from these three haplotypes was found.
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